| 3 5 EXONUCLEASE ACTIVITY |
GO_-_Molecular_Function.gmt.txt |
-2.8 |
0.04505 |
5.0 |
3.0 |
0.69 |
| ACTGCCT,MIR-34B |
TFmiRNA_Targets.gmt.txt |
-3.8 |
0.03976 |
101.0 |
27.0 |
13.95 |
| ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY |
GO_-_Molecular_Function.gmt.txt |
-3.0 |
0.03452 |
42.0 |
13.0 |
5.8 |
| AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY |
GO_-_Molecular_Function.gmt.txt |
-2.7 |
0.04505 |
8.0 |
4.0 |
1.11 |
| ARMS-mediated activation |
Pathways_-_Reactome.gmt.txt |
-2.2 |
0.04602 |
10.0 |
4.0 |
1.38 |
| ATPASE ACTIVITY COUPLED |
GO_-_Molecular_Function.gmt.txt |
-2.6 |
0.04853 |
50.0 |
14.0 |
6.91 |
| Activation of DNA fragmentation factor |
Pathways_-_Reactome.gmt.txt |
-3.1 |
0.01364 |
7.0 |
4.0 |
0.97 |
| Activation of Pro-Caspase 8 |
Pathways_-_Reactome.gmt.txt |
-2.8 |
0.01969 |
5.0 |
3.0 |
0.69 |
| Advanced glycosylation endproduct receptor signaling |
Pathways_-_Reactome.gmt.txt |
-2.4 |
0.035 |
6.0 |
3.0 |
0.83 |
| Apoptosis |
Pathways_-_Reactome.gmt.txt |
-3.0 |
0.01417 |
85.0 |
22.0 |
11.74 |
| Apoptosis induced DNA fragmentation |
Pathways_-_Reactome.gmt.txt |
-3.1 |
0.01364 |
7.0 |
4.0 |
0.97 |
| Apoptotic execution phase |
Pathways_-_Reactome.gmt.txt |
-2.2 |
0.04349 |
26.0 |
8.0 |
3.59 |
| BIOCARTA CERAMIDE PATHWAY |
Pathways_-_KEGGBioCarta.gmt.txt |
-2.5 |
0.04198 |
12.0 |
5.0 |
1.66 |
| BIOCARTA CHREBP2 PATHWAY |
Pathways_-_KEGGBioCarta.gmt.txt |
-4.2 |
0.01271 |
26.0 |
11.0 |
3.59 |
| BIOCARTA DNAFRAGMENT PATHWAY |
Pathways_-_KEGGBioCarta.gmt.txt |
-2.4 |
0.0481 |
6.0 |
3.0 |
0.83 |
| BIOCARTA ERK PATHWAY |
Pathways_-_KEGGBioCarta.gmt.txt |
-2.9 |
0.03048 |
14.0 |
6.0 |
1.93 |
| BIOCARTA IL2RB PATHWAY |
Pathways_-_KEGGBioCarta.gmt.txt |
-2.8 |
0.03296 |
22.0 |
8.0 |
3.04 |
| BIOCARTA IL4 PATHWAY |
Pathways_-_KEGGBioCarta.gmt.txt |
-2.4 |
0.0481 |
6.0 |
3.0 |
0.83 |
| BIOCARTA MCALPAIN PATHWAY |
Pathways_-_KEGGBioCarta.gmt.txt |
-2.4 |
0.0481 |
6.0 |
3.0 |
0.83 |
| BIOCARTA SODD PATHWAY |
Pathways_-_KEGGBioCarta.gmt.txt |
-2.4 |
0.0481 |
6.0 |
3.0 |
0.83 |
| BIOCARTA TNFR1 PATHWAY |
Pathways_-_KEGGBioCarta.gmt.txt |
-3.8 |
0.01271 |
17.0 |
8.0 |
2.35 |
| BIOPOLYMER METABOLIC PROCESS |
GO_-_Biological_Process.gmt.txt |
-6.9 |
1.8E-4 |
813.0 |
162.0 |
112.32 |
| CCAATNNSNNNGCG UNKNOWN |
TFmiRNA_Targets.gmt.txt |
-4.3 |
0.01708 |
22.0 |
10.0 |
3.04 |
| CGTSACG V$PAX3 B |
TFmiRNA_Targets.gmt.txt |
-4.3 |
0.01708 |
45.0 |
16.0 |
6.22 |
| Caspase-8 is formed from procaspase-8 |
Pathways_-_Reactome.gmt.txt |
-2.8 |
0.01969 |
5.0 |
3.0 |
0.69 |
| Cell Cycle |
Pathways_-_Reactome.gmt.txt |
-3.2 |
0.01223 |
260.0 |
54.0 |
35.92 |
| ChREBP activates metabolic gene expression |
Pathways_-_Reactome.gmt.txt |
-4.3 |
0.00422 |
5.0 |
4.0 |
0.69 |
| Chromosome Maintenance |
Pathways_-_Reactome.gmt.txt |
-2.5 |
0.03236 |
62.0 |
16.0 |
8.57 |
| DNA BINDING |
GO_-_Molecular_Function.gmt.txt |
-4.9 |
0.0108 |
271.0 |
62.0 |
37.44 |
| DNA METABOLIC PROCESS |
GO_-_Biological_Process.gmt.txt |
-3.2 |
0.03669 |
140.0 |
33.0 |
19.34 |
| DNA REPLICATION |
GO_-_Biological_Process.gmt.txt |
-3.9 |
0.02124 |
61.0 |
19.0 |
8.43 |
| DRUG BINDING |
GO_-_Molecular_Function.gmt.txt |
-3.1 |
0.03452 |
10.0 |
5.0 |
1.38 |
| Death Receptor Signalling |
Pathways_-_Reactome.gmt.txt |
-2.4 |
0.035 |
6.0 |
3.0 |
0.83 |
| Disease |
Pathways_-_Reactome.gmt.txt |
-4.4 |
0.00382 |
343.0 |
73.0 |
47.39 |
| Extrinsic Pathway for Apoptosis |
Pathways_-_Reactome.gmt.txt |
-2.4 |
0.035 |
6.0 |
3.0 |
0.83 |
| FRS2-mediated cascade |
Pathways_-_Reactome.gmt.txt |
-2.4 |
0.03389 |
9.0 |
4.0 |
1.24 |
| Frs2-mediated activation |
Pathways_-_Reactome.gmt.txt |
-2.4 |
0.03389 |
9.0 |
4.0 |
1.24 |
| G0 and Early G1 |
Pathways_-_Reactome.gmt.txt |
-3.6 |
0.00878 |
18.0 |
8.0 |
2.49 |
| GGGAGGRR V$MAZ Q6 |
TFmiRNA_Targets.gmt.txt |
-3.6 |
0.04558 |
665.0 |
122.0 |
91.87 |
| GRB2 events in EGFR signaling |
Pathways_-_Reactome.gmt.txt |
-2.7 |
0.02251 |
8.0 |
4.0 |
1.11 |
| GRB2 events in ERBB2 signaling |
Pathways_-_Reactome.gmt.txt |
-2.4 |
0.03389 |
9.0 |
4.0 |
1.24 |
| Gene Expression |
Pathways_-_Reactome.gmt.txt |
-3.6 |
0.00878 |
484.0 |
93.0 |
66.87 |
| Glycolysis |
Pathways_-_Reactome.gmt.txt |
-2.1 |
0.04915 |
18.0 |
6.0 |
2.49 |
| HIV Abortive elongation of HIV-1 transcript in the absence of Tat |
HIV_Collection.gmt.txt |
-2.3 |
0.04625 |
17.0 |
6.0 |
2.35 |
| HIV Early Phase of HIV Life Cycle |
HIV_Collection.gmt.txt |
-2.8 |
0.02864 |
11.0 |
5.0 |
1.52 |
| HIV HIV Infection |
HIV_Collection.gmt.txt |
-2.6 |
0.03465 |
135.0 |
30.0 |
18.65 |
| HIV A0EXI8 GAG |
HIV_Collection.gmt.txt |
-2.4 |
0.04111 |
9.0 |
4.0 |
1.24 |
| HIV A0EXJ0 VIF |
HIV_Collection.gmt.txt |
-2.7 |
0.03088 |
8.0 |
4.0 |
1.11 |
| HIV A0EXJ2 TAT |
HIV_Collection.gmt.txt |
-3.0 |
0.0246 |
71.0 |
19.0 |
9.81 |
| HIV A0EXJ3 REV |
HIV_Collection.gmt.txt |
-2.5 |
0.03741 |
12.0 |
5.0 |
1.66 |
| HIV O73199 GAG |
HIV_Collection.gmt.txt |
-2.8 |
0.02864 |
18.0 |
7.0 |
2.49 |
| HIV Q1H8S9 GP41 |
HIV_Collection.gmt.txt |
-2.8 |
0.02864 |
5.0 |
3.0 |
0.69 |
| INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY |
GO_-_Molecular_Function.gmt.txt |
-2.8 |
0.04505 |
5.0 |
3.0 |
0.69 |
| INTEGRATOR COMPLEX |
GO_-_Cellular_Component.gmt.txt |
-2.8 |
0.03238 |
11.0 |
5.0 |
1.52 |
| INTRACELLULAR NON MEMBRANE BOUND ORGANELLE |
GO_-_Cellular_Component.gmt.txt |
-4.7 |
0.00173 |
324.0 |
71.0 |
44.76 |
| INTRACELLULAR ORGANELLE PART |
GO_-_Cellular_Component.gmt.txt |
-3.6 |
0.00839 |
665.0 |
122.0 |
91.87 |
| Integration of energy metabolism |
Pathways_-_Reactome.gmt.txt |
-2.5 |
0.03236 |
47.0 |
13.0 |
6.49 |
| Interleukin-6 signaling |
Pathways_-_Reactome.gmt.txt |
-2.4 |
0.035 |
6.0 |
3.0 |
0.83 |
| KEGG ARGININE AND PROLINE METABOLISM |
Pathways_-_KEGGBioCarta.gmt.txt |
-3.6 |
0.01614 |
18.0 |
8.0 |
2.49 |
| KEGG CELL CYCLE |
Pathways_-_KEGGBioCarta.gmt.txt |
-2.7 |
0.0349 |
74.0 |
19.0 |
10.22 |
| KEGG GLYCOLYSIS GLUCONEOGENESIS |
Pathways_-_KEGGBioCarta.gmt.txt |
-2.3 |
0.04936 |
25.0 |
8.0 |
3.45 |
| KEGG LIMONENE AND PINENE DEGRADATION |
Pathways_-_KEGGBioCarta.gmt.txt |
-3.4 |
0.01799 |
4.0 |
3.0 |
0.55 |
| KEGG LYSINE DEGRADATION |
Pathways_-_KEGGBioCarta.gmt.txt |
-4.2 |
0.01271 |
26.0 |
11.0 |
3.59 |
| KEGG PATHOGENIC ESCHERICHIA COLI INFECTION |
Pathways_-_KEGGBioCarta.gmt.txt |
-3.9 |
0.01271 |
35.0 |
13.0 |
4.84 |
| KEGG PRION DISEASES |
Pathways_-_KEGGBioCarta.gmt.txt |
-3.1 |
0.02854 |
10.0 |
5.0 |
1.38 |
| Lysosome Vesicle Biogenesis |
Pathways_-_Reactome.gmt.txt |
-2.5 |
0.03236 |
16.0 |
6.0 |
2.21 |
| MEK activation |
Pathways_-_Reactome.gmt.txt |
-2.8 |
0.01969 |
5.0 |
3.0 |
0.69 |
| MEMBRANE ENCLOSED LUMEN |
GO_-_Cellular_Component.gmt.txt |
-4.7 |
0.00173 |
274.0 |
62.0 |
37.85 |
| MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION |
GO_-_Biological_Process.gmt.txt |
-3.1 |
0.0415 |
7.0 |
4.0 |
0.97 |
| Meiosis |
Pathways_-_Reactome.gmt.txt |
-2.3 |
0.03619 |
34.0 |
10.0 |
4.7 |
| Meiotic Synapsis |
Pathways_-_Reactome.gmt.txt |
-3.1 |
0.01332 |
24.0 |
9.0 |
3.32 |
| Metabolism of RNA |
Pathways_-_Reactome.gmt.txt |
-3.9 |
0.00596 |
178.0 |
42.0 |
24.59 |
| Metabolism of mRNA |
Pathways_-_Reactome.gmt.txt |
-4.8 |
0.00318 |
149.0 |
39.0 |
20.59 |
| NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION AND BIOGENESIS |
GO_-_Biological_Process.gmt.txt |
-3.1 |
0.0415 |
13.0 |
6.0 |
1.8 |
| NEGATIVE REGULATION OF CELLULAR METABOLIC PROCESS |
GO_-_Biological_Process.gmt.txt |
-3.0 |
0.04691 |
123.0 |
29.0 |
16.99 |
| NEGATIVE REGULATION OF CELLULAR PROTEIN METABOLIC PROCESS |
GO_-_Biological_Process.gmt.txt |
-3.5 |
0.03175 |
15.0 |
7.0 |
2.07 |
| NEGATIVE REGULATION OF DNA METABOLIC PROCESS |
GO_-_Biological_Process.gmt.txt |
-4.1 |
0.01565 |
10.0 |
6.0 |
1.38 |
| NEGATIVE REGULATION OF DNA REPLICATION |
GO_-_Biological_Process.gmt.txt |
-3.6 |
0.02851 |
6.0 |
4.0 |
0.83 |
| NEGATIVE REGULATION OF METABOLIC PROCESS |
GO_-_Biological_Process.gmt.txt |
-2.9 |
0.04823 |
124.0 |
29.0 |
17.13 |
| NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS |
GO_-_Biological_Process.gmt.txt |
-3.0 |
0.04404 |
17.0 |
7.0 |
2.35 |
| NEUTRAL AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY |
GO_-_Molecular_Function.gmt.txt |
-2.8 |
0.04505 |
5.0 |
3.0 |
0.69 |
| NEUTRAL AMINO ACID TRANSPORT |
GO_-_Biological_Process.gmt.txt |
-3.4 |
0.03264 |
4.0 |
3.0 |
0.55 |
| NON MEMBRANE BOUND ORGANELLE |
GO_-_Cellular_Component.gmt.txt |
-4.7 |
0.00173 |
324.0 |
71.0 |
44.76 |
| NUCLEAR LUMEN |
GO_-_Cellular_Component.gmt.txt |
-6.0 |
1.8E-4 |
231.0 |
58.0 |
31.91 |
| NUCLEAR PART |
GO_-_Cellular_Component.gmt.txt |
-6.2 |
1.4E-4 |
335.0 |
78.0 |
46.28 |
| NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS |
GO_-_Biological_Process.gmt.txt |
-5.9 |
0.00108 |
620.0 |
126.0 |
85.66 |
| NUCLEOLUS |
GO_-_Cellular_Component.gmt.txt |
-7.0 |
3.0E-5 |
76.0 |
28.0 |
10.5 |
| NUCLEUS |
GO_-_Cellular_Component.gmt.txt |
-8.6 |
0.0 |
751.0 |
159.0 |
103.75 |
| Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
Pathways_-_Reactome.gmt.txt |
-3.6 |
0.00878 |
69.0 |
20.0 |
9.53 |
| Nonsense Mediated Decay Independent of the Exon Junction Complex |
Pathways_-_Reactome.gmt.txt |
-2.4 |
0.035 |
58.0 |
15.0 |
8.01 |
| Nonsense-Mediated Decay |
Pathways_-_Reactome.gmt.txt |
-3.6 |
0.00878 |
69.0 |
20.0 |
9.53 |
| ORGANELLE LUMEN |
GO_-_Cellular_Component.gmt.txt |
-4.7 |
0.00173 |
274.0 |
62.0 |
37.85 |
| ORGANELLE ORGANIZATION AND BIOGENESIS |
GO_-_Biological_Process.gmt.txt |
-3.3 |
0.03669 |
241.0 |
51.0 |
33.3 |
| ORGANELLE PART |
GO_-_Cellular_Component.gmt.txt |
-3.6 |
0.00839 |
665.0 |
122.0 |
91.87 |
| PD-1 signaling |
Pathways_-_Reactome.gmt.txt |
-2.4 |
0.035 |
6.0 |
3.0 |
0.83 |
| PROTEIN PHOSPHATASE TYPE 2A REGULATOR ACTIVITY |
GO_-_Molecular_Function.gmt.txt |
-3.1 |
0.03452 |
10.0 |
5.0 |
1.38 |
| Platelet sensitization by LDL |
Pathways_-_Reactome.gmt.txt |
-2.2 |
0.04602 |
10.0 |
4.0 |
1.38 |
| Prolonged ERK activation events |
Pathways_-_Reactome.gmt.txt |
-2.2 |
0.04602 |
10.0 |
4.0 |
1.38 |
| RAF activation |
Pathways_-_Reactome.gmt.txt |
-3.4 |
0.00951 |
4.0 |
3.0 |
0.55 |
| RAF phosphorylates MEK |
Pathways_-_Reactome.gmt.txt |
-2.8 |
0.01969 |
5.0 |
3.0 |
0.69 |
| RAF/MAP kinase cascade |
Pathways_-_Reactome.gmt.txt |
-3.1 |
0.01364 |
7.0 |
4.0 |
0.97 |
| REGULATION OF CELLULAR METABOLIC PROCESS |
GO_-_Biological_Process.gmt.txt |
-5.5 |
0.00131 |
372.0 |
82.0 |
51.39 |
| REGULATION OF DNA REPLICATION |
GO_-_Biological_Process.gmt.txt |
-3.4 |
0.03264 |
9.0 |
5.0 |
1.24 |
| REGULATION OF METABOLIC PROCESS |
GO_-_Biological_Process.gmt.txt |
-5.5 |
0.00131 |
377.0 |
83.0 |
52.08 |
| REGULATION OF NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS |
GO_-_Biological_Process.gmt.txt |
-3.8 |
0.02505 |
298.0 |
63.0 |
41.17 |
| REGULATION OF PROTEIN STABILITY |
GO_-_Biological_Process.gmt.txt |
-3.1 |
0.0415 |
7.0 |
4.0 |
0.97 |
| REGULATION OF RNA METABOLIC PROCESS |
GO_-_Biological_Process.gmt.txt |
-3.2 |
0.03669 |
230.0 |
49.0 |
31.78 |
| REGULATION OF TRANSCRIPTIONDNA DEPENDENT |
GO_-_Biological_Process.gmt.txt |
-2.9 |
0.04823 |
226.0 |
47.0 |
31.22 |
| RNA BINDING |
GO_-_Molecular_Function.gmt.txt |
-3.2 |
0.03238 |
135.0 |
32.0 |
18.65 |
| RNA CATABOLIC PROCESS |
GO_-_Biological_Process.gmt.txt |
-3.1 |
0.04193 |
10.0 |
5.0 |
1.38 |
| RNA METABOLIC PROCESS |
GO_-_Biological_Process.gmt.txt |
-5.6 |
0.00119 |
414.0 |
90.0 |
57.2 |
| RNA PROCESSING |
GO_-_Biological_Process.gmt.txt |
-4.1 |
0.01565 |
92.0 |
26.0 |
12.71 |
| Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
Pathways_-_Reactome.gmt.txt |
-2.5 |
0.03236 |
62.0 |
16.0 |
8.57 |
| SHC-mediated signalling |
Pathways_-_Reactome.gmt.txt |
-2.4 |
0.03389 |
9.0 |
4.0 |
1.24 |
| SHC-related events |
Pathways_-_Reactome.gmt.txt |
-2.2 |
0.04602 |
10.0 |
4.0 |
1.38 |
| SHC1 events in EGFR signaling |
Pathways_-_Reactome.gmt.txt |
-2.4 |
0.03389 |
9.0 |
4.0 |
1.24 |
| SHC1 events in ERBB2 signaling |
Pathways_-_Reactome.gmt.txt |
-2.2 |
0.04602 |
10.0 |
4.0 |
1.38 |
| SHC1 events in ERBB4 signaling |
Pathways_-_Reactome.gmt.txt |
-2.2 |
0.04602 |
10.0 |
4.0 |
1.38 |
| SOS-mediated signalling |
Pathways_-_Reactome.gmt.txt |
-3.4 |
0.01001 |
9.0 |
5.0 |
1.24 |
| Signalling to p38 via RIT and RIN |
Pathways_-_Reactome.gmt.txt |
-2.4 |
0.03389 |
9.0 |
4.0 |
1.24 |
| TGTTTGY V$HNF3 Q6 |
TFmiRNA_Targets.gmt.txt |
-3.5 |
0.04593 |
173.0 |
40.0 |
23.9 |
| TNF signaling |
Pathways_-_Reactome.gmt.txt |
-3.4 |
0.00951 |
4.0 |
3.0 |
0.55 |
| TRANSCRIPTION ACTIVATOR ACTIVITY |
GO_-_Molecular_Function.gmt.txt |
-4.4 |
0.0108 |
80.0 |
24.0 |
11.05 |
| TRANSCRIPTION COACTIVATOR ACTIVITY |
GO_-_Molecular_Function.gmt.txt |
-3.2 |
0.03238 |
59.0 |
17.0 |
8.15 |
| TRANSCRIPTION FACTOR ACTIVITY |
GO_-_Molecular_Function.gmt.txt |
-4.0 |
0.01502 |
149.0 |
37.0 |
20.59 |
| Translocation of ZAP-70 to Immunological synapse |
Pathways_-_Reactome.gmt.txt |
-2.4 |
0.035 |
6.0 |
3.0 |
0.83 |
| V$E2F1 Q4 |
TFmiRNA_Targets.gmt.txt |
-3.7 |
0.03976 |
87.0 |
24.0 |
12.02 |
| V$E2F1 Q4 01 |
TFmiRNA_Targets.gmt.txt |
-4.3 |
0.01708 |
85.0 |
25.0 |
11.74 |
| V$E2F1 Q6 01 |
TFmiRNA_Targets.gmt.txt |
-4.3 |
0.01708 |
95.0 |
27.0 |
13.12 |
| V$E2F Q3 01 |
TFmiRNA_Targets.gmt.txt |
-4.3 |
0.01708 |
85.0 |
25.0 |
11.74 |
| V$MYCMAX 01 |
TFmiRNA_Targets.gmt.txt |
-4.8 |
0.0115 |
90.0 |
27.0 |
12.43 |
| V$NFMUE1 Q6 |
TFmiRNA_Targets.gmt.txt |
-5.0 |
0.01046 |
111.0 |
32.0 |
15.34 |
| chr10q24 |
Chromosomal_Bands.gmt.txt |
-3.1 |
0.01679 |
37.0 |
12.0 |
5.11 |
| chr11q25 |
Chromosomal_Bands.gmt.txt |
-2.4 |
0.02814 |
6.0 |
3.0 |
0.83 |
| chr16p11 |
Chromosomal_Bands.gmt.txt |
-2.5 |
0.02637 |
42.0 |
12.0 |
5.8 |
| chr16p13 |
Chromosomal_Bands.gmt.txt |
-2.3 |
0.03202 |
102.0 |
23.0 |
14.09 |
| chr19p13 |
Chromosomal_Bands.gmt.txt |
-2.9 |
0.01768 |
191.0 |
41.0 |
26.39 |
| chr1p36 |
Chromosomal_Bands.gmt.txt |
-2.9 |
0.01693 |
118.0 |
28.0 |
16.3 |
| chr1q21 |
Chromosomal_Bands.gmt.txt |
-2.4 |
0.028 |
83.0 |
20.0 |
11.47 |
| chr1q22 |
Chromosomal_Bands.gmt.txt |
-2.1 |
0.0424 |
32.0 |
9.0 |
4.42 |
| chr20q11 |
Chromosomal_Bands.gmt.txt |
-2.0 |
0.04408 |
42.0 |
11.0 |
5.8 |
| chr22q12 |
Chromosomal_Bands.gmt.txt |
-2.6 |
0.02304 |
36.0 |
11.0 |
4.97 |
| chr22q13 |
Chromosomal_Bands.gmt.txt |
-2.4 |
0.028 |
68.0 |
17.0 |
9.39 |
| chr6p21 |
Chromosomal_Bands.gmt.txt |
-2.1 |
0.03989 |
133.0 |
28.0 |
18.37 |
| chr7q11 |
Chromosomal_Bands.gmt.txt |
-2.0 |
0.04729 |
28.0 |
8.0 |
3.87 |
| chr7q31 |
Chromosomal_Bands.gmt.txt |
-2.1 |
0.04022 |
14.0 |
5.0 |
1.93 |
| hsa-miR-133a targets |
TarBase_6beta.gmt.txt |
-3.0 |
0.03443 |
17.0 |
7.0 |
2.35 |
| hsa-miR-16-5p targets |
TarBase_6beta.gmt.txt |
-3.6 |
0.01523 |
458.0 |
89.0 |
63.28 |
| hsa-miR-34a-5p targets |
TarBase_6beta.gmt.txt |
-4.5 |
0.004 |
216.0 |
51.0 |
29.84 |
| hsa-miR-98 targets |
TarBase_6beta.gmt.txt |
-4.4 |
0.00415 |
240.0 |
55.0 |
33.16 |
| hsa-miR-99a-5p targets |
TarBase_6beta.gmt.txt |
-4.3 |
0.00463 |
5.0 |
4.0 |
0.69 |
Figure: Temporal expression patterns were grouped into clusters with differential expression profiles at
three phases of the viral life cycle, namely reverse transcription, integration, and late phase.
Boxplots on the left show the distribution of the normalized regression weights for each viral phase used in clustering.
Expression change pattern of each gene over time is plotted for mock and HIV samples (dotted orange lines) along with the cluster median (bold red line).